{"id":16248,"date":"2024-07-22T12:49:12","date_gmt":"2024-07-22T10:49:12","guid":{"rendered":"https:\/\/pharmavalue.it\/?p=16248"},"modified":"2024-07-22T12:49:12","modified_gmt":"2024-07-22T10:49:12","slug":"aifa-administrative-sanctions","status":"publish","type":"post","link":"https:\/\/pharmavalue.it\/en\/aifa-administrative-sanctions\/","title":{"rendered":"AIFA administrative sanctions"},"content":{"rendered":"<h2><strong>Clarification of AIFA Administrative Sanctions<\/strong><\/h2>\n<p>The law recognises in AIFA - as the Drug Regulatory Authority - the power to apply pecuniary sanctions in the event of violation of specific sector regulations (see, among these, the sanctions provided for in Article 42(1) of Legislative Decree No. 200\/2007 and Article 2(7) of Legislative Decree No. 17\/2014).<\/p>\n<p>But how exactly does this process work?<\/p>\n<p>Here are the main steps involved.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>The first phase of the process<\/strong><\/h3>\n<p>Following a challenge by AIFA, the person concerned may decide to:<\/p>\n<p>- <strong>Paying the penalty<\/strong>The person concerned may choose to pay the penalty in a reduced amount, <strong>within 60 days<\/strong> from receipt of the objection.<\/p>\n<p>- <strong>Contesting the sanction<\/strong>If the person concerned considers that the sanction is unjustified, he\/she has <strong>30 days<\/strong> to send defence papers, documents and a request for a hearing.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<h3><strong>Hearing of the parties: Hearing<\/strong><\/h3>\n<p>After receiving the complaint, the competent office of AIFA will examine the file, evaluate the defence and, if necessary, hear the person concerned.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<h3><strong>Finalisation of the file: the decision<\/strong><\/h3>\n<p>Once the file has been completed, the relevant office of AIFA will make a decision, and if it considers:<\/p>\n<p>- <strong>the finding to be well-founded:<\/strong> the competent office determines the amount of the sanction and orders its payment;<\/p>\n<p>- <strong>the unfounded finding<\/strong>order is issued.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<h3><strong>Execution of the sanction<\/strong><\/h3>\n<p>The payment order constitutes an enforcement order. If payment is not made within 30 days (60 days for residents abroad), AIFA will initiate compulsory collection through the Agenzia delle Entrate - Riscossione.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<h3><strong>Opposition by the interested party<\/strong><\/h3>\n<p>It is always possible to oppose the injunction order before the ordinary court.<\/p>\n<p><span class=\"x1c3i2sq x19la9d6 x1fc57z9 xexx8yu x19um543 x18d9i69 x1m6msm x6ikm8r x10wlt62 x19co3pv x1g5zs5t xfibh0p xiy17q3 x1xsqp64\"><span class=\"\">\u2b07\ufe0f <\/span><\/span>Below is an illustrative diagram of the entire process.<\/p>\n<p>You can read the <a href=\"https:\/\/www.aifa.gov.it\/-\/chiarimenti-sul-procedimento-di-irrogazione-di-sanzioni-amministrative-pecuniarie\">AIFA press release of 6 June<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>More news about AIFA<\/strong><\/h4>\n<p>Pharma Value is always at the forefront in disseminating the main news concerning the Italian Medicines Agency, such as <a href=\"https:\/\/pharmavalue.it\/en\/special-new-aifa-cse-and-reorganisation\/\">the Update on the new CSE (Scientific and Economic Commission) and the AIFA reorganisation<\/a>on the basis of the amendments requested by the State-Regions Conference and the Council of State.<\/p>\n<p>In another article we also wrote about the \"<a href=\"https:\/\/pharmavalue.it\/en\/technical-table-review-of-aifa-and-pt-notes\/\">Technical Table for the revision of AIFA Notes and Therapeutic Plans (PT)<\/a>\" in support of the Scientific and Economic Commission for Medicines (CSE).<\/p>\n<p>Keep following us to stay abreast of the most relevant updates!<\/p>\n<p>&nbsp;<\/p>\n<div class=\"_df_book df-lite\" id=\"df_16252\"  _slug=\"sanzioni-amministrative-aifa\" data-title=\"sanzioni-amministrative-aifa\" wpoptions=\"true\" thumbtype=\"\" ><\/div><script class=\"df-shortcode-script\" nowprocket type=\"application\/javascript\">window.option_df_16252 = {\"outline\":[],\"backgroundColor\":\"eeeeee\",\"duration\":\"0\",\"autoEnableOutline\":\"false\",\"autoEnableThumbnail\":\"false\",\"overwritePDFOutline\":\"false\",\"enableDownload\":\"true\",\"direction\":\"1\",\"pageSize\":\"0\",\"pageMode\":\"1\",\"soundEnable\":\"false\",\"autoPlay\":\"false\",\"source\":\"https:\\\/\\\/pharmavalue.it\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/2024_sanzioni-amministrative-AIFA_S3.pdf\",\"wpOptions\":\"true\"}; if(window.DFLIP && window.DFLIP.parseBooks){window.DFLIP.parseBooks();}<\/script>","protected":false},"excerpt":{"rendered":"<p>Chiarimenti sulle Sanzioni Amministrative AIFA La legge riconosce in capo ad AIFA \u2013 quale Autorit\u00e0 regolatoria del farmaco \u2013 il potere di applicare sanzioni pecuniarie in caso di violazione di specifiche norme di settore (vedasi, tra queste, le sanzioni previste da art. 42, comma 1, D.lgs. n. 200\/2007 e art. 2, comma 7, D.lgs. n. [&hellip;]<\/p>\n","protected":false},"author":314,"featured_media":16251,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"La legge riconosce in capo ad AIFA \u2013 quale Autorit\u00e0 regolatoria del farmaco \u2013 il potere di applicare sanzioni pecuniarie in caso di violazione di specifiche norme di settore (vedasi, tra queste, le sanzioni previste da art. 42, comma 1, D.lgs. n. 200\/2007 e art. 2, comma 7, D.lgs. n. 17\/2014).","_seopress_robots_index":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-16248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-appunti"],"_links":{"self":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts\/16248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/users\/314"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/comments?post=16248"}],"version-history":[{"count":0,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/posts\/16248\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/media\/16251"}],"wp:attachment":[{"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/media?parent=16248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/categories?post=16248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmavalue.it\/en\/wp-json\/wp\/v2\/tags?post=16248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}